Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2017 08:30 ET | Source: ProPhase Labs

ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2017

DOYLESTOWN, PA--(Marketwired - May 15, 2017) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its financial results for the three months ended March 31, 2017. As previously...
April 05, 2017 16:10 ET | Source: ProPhase Labs

ProPhase Provides Shareholder Update

DOYLESTOWN, PA--(Marketwired - April 05, 2017) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the "Company"), provides an update to...
March 29, 2017 16:30 ET | Source: ProPhase Labs

ProPhase Labs, Inc. Completes Sale of Cold-EEZE(R) Business to Mylan

DOYLESTOWN, PA--(Marketwired - March 29, 2017) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the "Company"), announced today that...
February 27, 2017 08:00 ET | Source: ProPhase Labs

ProPhase Labs Reports Financial Results for the Year Ended December 31, 2016

DOYLESTOWN, PA--(Marketwired - February 27, 2017) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $21.0 million for the year ended December 31, 2016 as...
January 09, 2017 07:35 ET | Source: ProPhase Labs

ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM

DOYLESTOWN, PA--(Marketwired - January 09, 2017) - ProPhase Labs (NASDAQ: PRPH) announced earlier today an agreement to sell its Cold-EEZE® cold remedy brand. A conference call will be held on...
January 09, 2017 07:30 ET | Source: ProPhase Labs

ProPhase Labs, Inc. Announces Agreement to Sell Cold-EEZE(R) Brand

DOYLESTOWN, PA--(Marketwired - January 09, 2017) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the "Company"), announced today...
November 16, 2016 16:30 ET | Source: ProPhase Labs

ProPhase Labs Reports Arbitration Decision In Phusion Laboratories/Phosphagenics Dispute

DOYLESTOWN, PA--(Marketwired - November 16, 2016) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported that the arbitration case that has been ongoing since October 2014 with...
November 14, 2016 08:00 ET | Source: ProPhase Labs

ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2016

DOYLESTOWN, PA--(Marketwired - November 14, 2016) - ProPhase Labs, Inc.(NASDAQ: PRPH) www.ProPhaseLabs.com today reported its net sales were $5.2 million for the three months ended September 30, 2016...
August 09, 2016 18:15 ET | Source: ProPhase Labs

ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2016; Exploring Strategic Alternatives to Enhance Shareholder Value

DOYLESTOWN, PA--(Marketwired - August 09, 2016) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $2.8 million for the three months ended June 30, 2016 as...
August 05, 2016 12:11 ET | Source: ProPhase Labs

ProPhase Labs to Release Second Quarter 2016 Results on Tuesday, August 9th

DOYLESTOWN, PA--(Marketwired - August 05, 2016) - ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the second quarter, ended June 30, 2016, will be released after the market...